Events
Carestream will introduce a three-dimensional extension of general radiography through its Digital Tomosynthesis functionality clearance) at this year’s Radiological Society of North America conference in booth #7513, North Hall..
MorphoSys AG announced presentation of so far unpublished data on tafasitamab, its proprietary key asset and investigational hemato-oncological drug candidate, at the upcoming 61th American Society of Hematology 2019 Annual Meeting, taking place from December 7-10, 2019 in Orlando, Florida.
Summit Therapeutics plc announces that management will participate in two panel sessions at the World Antimicrobial Resistance Congress, taking place 7-8 November 2019 in Washington, DC.
Presentation at SITC Shows Potential to Flag Solid Tumours as a Target for the Immune System to Attack Using the Company’s DCOne® Cell Vaccine Loaded with a Foreign Antigen
Martinsried/ Munich Medigene AG announces that immune monitoring data during the first year of treatment from the ongoing Phase I / II clinical trial with Medigene’s DC vaccine for the treatment of acute myeloid leukemia will be presented at the upcoming ASH Annual Meeting taking place 7 - 10 December 2019 in Orlando, Florida, USA.
ADC Therapeutics Announces Presentations at 61st American Society of Hematology (ASH) Annual Meeting
Presentations highlight lead product candidate ADCT-402 as a single agent and in combination with checkpoint inhibitor durvalumab for relapsed or refractory B-cell non-Hodgkin lymphomas
Heidelberg Pharma AG announced that they will participate at the following investor events and scientific conferences.
Dr. Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with a further 11 outstanding winners unveiled
Event provides a perfect partnering platform to exchange with industry executives and to look for novel approaches to fight antimicrobial resistance
walk2Wellness interim study data demonstrate improvement in balance, walking speed and fall reduction
PRESS RELEASES